Search

everythinglearnresearchcommunity

for

Search:↓

Dermatoscopy and videodermatoscopy are useful and reliable for tracking treatment progress in various skin conditions.

3D printing can make microneedles for drug delivery faster and cheaper.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Dermoscopic examination helps diagnose different types of hair loss conditions by showing specific patterns.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Alopecia Areata causes emotional stress and stigma, but those with severe hair loss may adapt better.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

The COVID-19 pandemic led to an increase in untreated hair diseases and showed the importance of teledermatology.

Using steroids can increase the risk of heart problems.

People with Major Depressive Disorder have a higher chance of getting Alopecia Areata, and vice versa; antidepressants may lower this risk.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

The research found specific signs to diagnose alopecia areata incognito and noted patients generally regrow hair after steroid treatment.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

Hyaluronic acid increases collagen synthesis safely, while poly-L-lactic acid may cause complications by affecting fibroblasts.

Lack of small, fine hair on the front hairline is a key sign of frontal fibrosing alopecia.

Chemotherapy can cause hair changes similar to alopecia areata, which might lead to misdiagnosis.

Skin pigmentation varies due to genetics, UV exposure, and medications, with treatments available but requiring medical advice.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.